Synthesis and Evaluation of 9‑Aminoacridines with SARS-CoV‑2 Antiviral Activity

• Thane Jones,
• Natalia Monakhova,
• Florence Guivel-Benhassine,
• Alexander Lepioshkin,
• Timothée Bruel,
• Thomas R. Lane,
• Olivier Schwartz,
• Ana C. Puhl,
• Vadim Makarov,
• Sean Ekins

Affiliations

Thane Jones

Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, United States

Natalia Monakhova

Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia

Florence Guivel-Benhassine

Institut Pasteur, Paris Cedex 15, France

Alexander Lepioshkin

Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia

Timothée Bruel

Institut Pasteur, Paris Cedex 15, France

Thomas R. Lane

Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, United States

Olivier Schwartz

Institut Pasteur, Paris Cedex 15, France

Ana C. Puhl

Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, United States

Vadim Makarov

Federal Research Centre “Fundamentals of Biotechnology” of the Russian Academy of Sciences (Research Centre of Biotechnology RAS), Moscow, Russia

Sean Ekins

Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, United States